| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Xian Ming | Director | C/O MEDIFAST, INC., 100 INTERNATIONAL DRIVE, BALTIMORE | /s/ Jason L. Groves, attorney-in-fact | 2025-06-26 | 0001743879 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MED | Restricted Stock Units (cash settled) | Award | $0 | +11.2K | +74.64% | $0.00 | 26.1K | Jun 25, 2025 | Common Stock | 11.2K | Direct | F1 | |
| transaction | MED | Restricted Stock Units (cash settled) | Award | $80.5K | +6.01K | +23.01% | $13.39 | 32.1K | Jun 25, 2025 | Common Stock | 6.01K | Direct | F2, F3 |
| Id | Content |
|---|---|
| F1 | Represents the contingent right to receive shares of the Issuer's common stock or the cash equivalent in connection with the payment of the reporting person's annual director fees, under the Medifast, Inc. Director's Deferred Compensation Plan, as Amended and Restated (the "Plan"). These shares are granted from the Issuer's Amended and Restated 2012 Share Incentive Plan and will vest in full on June 25, 2026. The restricted stock units will become payable in cash upon or following the reporting person's termination of service as a director of the Issuer pursuant to the terms of the Plan. |
| F2 | The reporting person elected, pursuant to the Plan, to receive shares of the Issuer's common stock in lieu of cash compensation of annual service as a non-employee director of the Issuer. The restricted stock units will become payable in cash upon or following the reporting person's termination of service as a director of the Issuer pursuant to the terms of the Plan. |
| F3 | The price per share of $13.39 is based on the 20-day moving average price of the Issuer's common stock as of June 6, 2025. |